Leap Therapeutics Profit Margin

Leap Therapeutics's profit margin stands at 17655.5% as of June 2026. That is above the Healthcare sector average of 10.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Leap Therapeutics sits higher the Healthcare benchmark (10.58%) with a profit margin of 17655.5%. That is roughly 166768.8% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 17655.5% for Leap Therapeutics means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Leap Therapeutics's profit margin evolved across reporting periods, while the comparison chart places LPTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, profit margin is commonly used to spot outliers. Leap Therapeutics's reading of 17655.5% (sector avg 10.58%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.